Journey Medical Corp expected to post a loss of 33 cents a share - Earnings Preview

Journey Medical

04/08/2023 23:24

* Journey Medical Corp  DERM.OQ   DERM.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 8. 
    * The Scottsdale Arizona-based  company is expected to
report  a
19.0% decrease in revenue to $14.808 million from $18.29 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Journey Medical
Corp is
for a loss of 33 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $5​, above​ its last closing price of $2.10. ​​​

This summary was machine generated August 4 at 22:24 GMT.  All
figures in US dollars  unless otherwise stated